CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
58.57
25-十一月-24 12:50:13
15 分钟延时
股票
+1.03
+1.79%
今日范围
57.50 - 59.16
ISIN
N/A
来源
NASDAQ
-
17 9月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
William Guyer to join Corcept as Chief Development Officer
12 8月 2021 17:00:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
29 7月 2021 16:05:03 条件 Nasdaq GlobeNewswire
-
12 7月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
22 6月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
15 6月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
10 6月 2021 07:30:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
06 5月 2021 16:10:00 条件 Nasdaq GlobeNewswire
-
06 5月 2021 16:01:01 条件 Nasdaq GlobeNewswire
-
29 4月 2021 16:05:01 条件 Nasdaq GlobeNewswire
-
15 3月 2021 07:30:00 条件 Nasdaq GlobeNewswire
-
01 3月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results
23 2月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
08 2月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
01 2月 2021 16:05:00 条件 Nasdaq GlobeNewswire